- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.04. | VITURA HEALTH LIMITED: Final Director's Interest Notice | - | ASX | ||
| 07.04. | VITURA HEALTH LIMITED: Resignation of Non-Executive Director | - | ASX | ||
| 02.04. | VITURA HEALTH LIMITED: Appointment of Chief Executive Officer | - | ASX | ||
| 29.03. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 22.03. | VITURA HEALTH LIMITED: Cortexa advances commercialisation of MDMA supply | - | ASX | ||
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| 17.03. | Vitura Health Signs Online Distribution Deal for MedReleaf Medicinal Cannabis Products | 2 | smallcaps.com.au | ||
| 16.03. | VITURA HEALTH LIMITED: VIT enters distribution agreement with MedReleaf Australia | - | ASX | ||
| 12.03. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Investor Presentation | 2 | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Results Release | 1 | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Results Investor Webinar | 3 | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Appendix 4D and Half Year Report | 2 | ASX | ||
| 23.02. | VITURA HEALTH LIMITED: Revised Trading Policy | 3 | ASX | ||
| 03.02. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | 1 | ASX | ||
| 28.01. | VITURA HEALTH LIMITED: CEO Transition and Interim Leadership Update | - | ASX | ||
| 11.01. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 09.01. | VITURA HEALTH LIMITED: Appointment of Chief Financial Officer | 3 | ASX | ||
| 05.01. | VITURA HEALTH LIMITED: Amended Constitution - Late Lodgement | - | ASX | ||
| 05.01. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 23.12.25 | VITURA HEALTH LIMITED: Change of Director's Interest Notice - Late Lodgement | 1 | ASX |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 2,992 | -0,80 % | Bioxyne unterzeichnet Herstellungsvereinbarung mit globalem Cannabisführer Aurora Cannabis | Die australische Bioxyne Limited (ASX: BXN) ("Bioxyne" oder "das Unternehmen") freut sich, über ihre hundertprozentige
Tochtergesellschaft Breathe Life Sciences (BLS) bekannt zu geben, dass sie... ► Artikel lesen | |
| TILRAY BRANDS | 5,860 | -0,17 % | Tilray Brands, Inc.: Tilray Expands Canadian Cannabis Portfolio with Launch of PORTAL, A New High Intensity Brand for the Experienced Consumer | TORONTO, April 08, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. company (Nasdaq: TLRY; TSX: TLRY) a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,244 | +2,13 % | Organigram Global Inc.: Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), is pleased to announce that the shareholders of Organigram have overwhelmingly approved the resolution required to... ► Artikel lesen | |
| SNDL | 1,226 | +4,52 % | SNDL Inc.: SNDL Announces Leadership Transition for Cannabis Segment | EDMONTON, Alberta, March 30, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) ("SNDL" or the "Company") announced today that Tyler Robson, President of Cannabis, has left the Company in... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 1,170 | 0,00 % | XFRA 0NF1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNOVERIS HEALTH SCI.... ► Artikel lesen | |
| WAYLAND GROUP | - | - | EQS-News: Berger Montague (Canada) PC: Ankündigung der Anhörung zur Genehmigung des Vergleichs - Wayland Group Corp., Scott Langille, Gerhard Müller, Paul Pathak, Eric Silver, M. Stein, John Does 1-3, Canaccord Genuity Corp. und RF Securities Clearing LP | EQS-News: Berger Montague (Canada) PC
/ Schlagwort(e): Rechtssache/Sonstiges
ANKÜNDIGUNG DER ANHÖRUNG ZUR GENEHMIGUNG DES VERGLEICHS - KURZFASSUNG - WAYLAND... ► Artikel lesen | |
| BIONANO GENOMICS | 1,205 | 0,00 % | Bionano Genomics stock price target lowered to $6 by H.C. Wainwright | ||
| TONIX PHARMACEUTICALS | 11,600 | +2,52 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and ... | Intranasal oxytocin blocks the release of calcitonin gene-related peptide (CGRP) in animal models and is the core technology of TNX-1900 for craniofacial pain conditions, including migraine and trigeminal... ► Artikel lesen | |
| HIGH TIDE | 1,948 | -1,52 % | High Tide wird auf mehreren bedeutenden internationalen Cannabis- und Investorenkonferenzen vertreten sein | CALGARY, AB, 13. April 2026 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (Nasdaq: HITI) (TSXV: HITI) (FWB: 2LYA), ein erfolgreiches und auf
den Einzelhandel ausgerichtetes... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 3,014 | +1,07 % | Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates | Achieve also Announces Partnership with U.S.-based Adare Pharma Solutions for Cytisinicline Manufacturing Conference Call Scheduled for 8:30 AM EDT Today, March 24, 2026 SEATTLE and VANCOUVER, British... ► Artikel lesen | |
| JAGUAR HEALTH | 0,400 | 0,00 % | Jaguar Health, Inc.: Artificial Intelligence Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure Programs | Global Market for Short Bowel Syndrome, Including Intestinal Failure (IF), Estimated to Reach $8.0 Billion by 20331AI data mining of real world clinical and symptom manifestation is beneficial in the... ► Artikel lesen | |
| MEDIPHARM LABS | 0,037 | -10,84 % | MediPharm Labs Corp.: MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue | FY 2025 revenue of $45.1 million, an increase of 8% over 2024International Medical Cannabis revenue increased 43% year-over-year and represented more than 50% of total revenueIncreased cash balance... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,013 | +18,18 % | ARGENT BIOPHARMA LIMITED: Completion of CannPal Asset Acquisition and Neuvis Option | ||
| AYR WELLNESS | 0,078 | -100,00 % | Ayr Wellness Inc.: AYR Wellness Announces Closing of Exit Facility and Related Transactions | MIAMI, April 10, 2026 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, announces the initial... ► Artikel lesen |
Das Unternehmen VITURA HEALTH LIMITED kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,016 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.